Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo

Pharmaceutical Research

Volumn 20, Issue 4, 2003, Pages 684-692

  Anraku, Makoto ^a   Kragh Hansen, Ulrich ^b   Kawai, Keiichi ^c   Maruyama, Toru ^a   Yamasaki, Yasuomi ^d   Takakura, Yoshinobu ^d   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b AARHUS UNIVERSITY   (Denmark)

^c KANAZAWA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Chloramine T; Cysteine mutation; Human serum albumin; Oxidative damage; Pharmacokinetics; Site II

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CYANOGEN BROMIDE; CYSTEINE; HUMAN SERUM ALBUMIN; KETOPROFEN; METHIONINE; TOSYLCHLORAMIDE SODIUM; TRYPTOPHAN; WARFARIN;

ARTICLE; BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME ACTIVITY; FLUORESCENCE; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IN VIVO STUDY; LIVER CLEARANCE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN PURIFICATION; REACTION ANALYSIS; VALIDATION PROCESS;

ANIMALS; CHLORAMINES; DISEASE MODELS, ANIMAL; HUMANS; MICE; MUTATION; OXIDATIVE STRESS; SERUM ALBUMIN; TOSYL COMPOUNDS;

EID: 12444344290     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023219420935     Document Type: Article

References (26)

1. I. Climent, L. Tsai, and R. L. Levine. Derivatization of γ-glutamyl semialdehyde residues in oxidized proteins by fluoresceinamine. Anal. Biochem. 182:226-232 (1989).
2. E. Bourdon, N. Loreau, and D. Blache. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13:233-244 (1999).
3. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 12:439-446 (1999).
4. M. Anraku, K. Yamasaki, T. Maruyama, U. Kragh-Hansen, and M. Otagiri. Effect of oxidative stress on the structure and function of human serum albumin. Pharm. Res. 18:632-639 (2001).
5. S. Era, T. Hamaguchi, M. Sogami, K. Kuwata, E. Suzuki, K. Miura, K. Kawai, Y. Kitazawa, H. Okabe, A. Noma, and S. Miyata. Further studies on the resolution of human mercapt- and non-mercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography. Int. J. Pept. Protein Res. 31:435-442 (1988).
6. M. Sogami, S. Nagaoka, S. Era, M. Honda, and K. Noguchi. Resolution of human mercapt and nonmercaptalbumin by high performance liquid chromatography. Int. J. Pept. Protein Res. 24:96-103 (1984).
7. M. Sogami, S. Era, S. Nagaoka, K. Kuwata, K. Kida, K. Miura, H. Inouye, E. Suzuki, S. Hayano, and S. Sawada. HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int. J. Pept. Protein Res. 24:398-402 (1985).
8. Y. Shechter, Y. Burstein, and A. Patchornik. Selective oxidation of methionine residues in proteins. Biochemistry 14:4497-4503 (1975).
9. R. F. Chen. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242:173-181 (1967).
10. S. Era, K. Kuwata, H. Imai, K. Nakamura, T. Hayashi, and M. Sogami. Age-related change in redox state of human serum albumin. Biochim. Biophys. Acta 1247:12-16 (1995).
11. H. Watanabe, K. Yamasaki, U. Kragh-Hansen, S. Tanase, K. Harada, A. Suenaga, and M. Otagiri. In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm. Res. 18:1775-1781 (2001).
12. T. Hayashi, S. Era, K. Kawai, H. Imai, K. Nakamura, E. Onda, and M. Yoh. Observation for redox state of human serum and aqueous humor albumin from patients with senile cataract. Pathophysiology 6:237-243 (2000).
13. K. Takabayashi, T. Imada, Y. Saito, and Y. Inada. Coupling between fatty acid binding and sulfhydryl oxidation in bovine serum albumin. Eur. J. Biochem. 136:291-295 (1983).
14. T. Zor and Z. Selinger. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236:302-308 (1996).
15. P. G. Pande, R. V. Nellore, and H. R. Bhagat. Optimization and validation of analytical conditions for bovine serum albumin using capillary electrophoresis. Anal. Biochem. 204:103-106 (1992).
16. P.M. Horowitz, S. Hua, and D. L. Gibbons. Hydrophobic surfaces that are hidden in chaperonin Cpn60 can be exposed by formation of assembly-competent monomers or by ionic perturbation of the oligomer. J. Biol. Chem. 207:1535-1542 (1995).
17. H. Watanabe, S. Tanase, K. Nakajou, T. Maruyama, U. Kragh-Hansen, and M. Otagiri. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem. J. 349:813-819 (2000).
18. Y. Takakura, T. Fujita, M. Hashida, and H. Sezaki. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7:339-346 (1990).
19. J.R. Duncan and M.J. Welch. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J. Nucl. Med. 34:1728-1738 (1993).
20. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. Pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4:879-885 (1981).
21. T. Mukai, Y. Arano, K. Nishida, H. Sasaki, H. Saji, and J. Nakamura. In-vivo evaluation of indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice. J. Pharm. Pharmacol. 51:15-20 (1999).
22. G. Sudlow, D. J. Birkett, and D. N. Wade. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11:824-832 (1975).
23. T. Peters, Jr. All about Albumin: Biochemistry, Genetics, and Medical Applications, Academic Press, San Diego, California, 1996.
24. V. T. G. Chuang, A. Kuniyasu, H. Nakayama, Y. Matsushita, S. Hirono, and M. Otagiri. Helix 6 of subdomain IIIA of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim. Biophys. Acta 1434:18-30 (1999).
25. H. Watanabe, U. Kragh-Hansen, S. Tanase, K. Nakajou, M. Mitarai, Y. Iwao, T. Maruyama, and M. Otagiri. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J. 357:269-274 (2001).
26. B. Smedsrod, J. Melkko, N. Araki, H. Sano, and S. Horiuchi. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal, Kupffer and endothelial cells. Biochem. J. 322:567-573 (1997).